Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CAM--a novel immunosuppressive agent

K Takazawa1, Y Hosoda, H Bashuda

  • 1Department of Cardiothoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Transplantation
|June 27, 1995
PubMed
Summary

This study shows CAM, a mycophenolic acid derivative, significantly improves heart allograft survival in rats compared to mycophenolate mofetil (MMF). CAM also induced donor-specific tolerance, a key finding for transplantation research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease.

Mucosal immunology·2015
Same author

Hes1 suppresses acute myeloid leukemia development through FLT3 repression.

Leukemia·2014
Same author

Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking.

Leukemia·2014
Same author

Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation.

Mucosal immunology·2014
Same author

Retinoic acid prevents mesenteric lymph node dendritic cells from inducing IL-13-producing inflammatory Th2 cells.

Mucosal immunology·2013
Same author

Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.

Mucosal immunology·2013

Area of Science:

  • Immunology
  • Transplantation Biology
  • Pharmacology

Background:

  • Allograft rejection remains a major challenge in organ transplantation.
  • Mycophenolate mofetil (MMF) is a widely used immunosuppressant.
  • Novel immunosuppressive agents are needed to improve graft survival and reduce toxicity.

Purpose of the Study:

  • To evaluate the immunosuppressive efficacy of CAM, a mycophenolic acid derivative, in a rat heart allograft model.
  • To compare the efficacy of CAM with mycophenolate mofetil (MMF) in prolonging heart allograft survival.
  • To investigate whether CAM induces donor-specific tolerance.

Main Methods:

  • A rat heart allograft model with fully mismatched major histocompatibility complexes was used.
  • Rats received oral administration of CAM or MMF from day 1 post-allografting for 40 days.

Related Experiment Videos

  • Graft survival, skin graft acceptance, and cellular immune responses were assessed.

    • Main Results:

    • CAM significantly prolonged median survival times (MST) of heart allografts in a dose-dependent manner.
    • CAM at 20 and 30 mg/kg resulted in MST >100 days, with all grafts surviving in the 30 mg/kg group.
    • CAM demonstrated superior efficacy over MMF in prolonging graft survival at all tested doses.
    • Long-term CAM treatment induced donor-specific tolerance, evidenced by acceptance of donor-strain skin grafts.
    • While proliferative responses were not impaired, cytotoxic T lymphocyte (CTL) activity and precursor frequency against donor antigens were reduced in tolerant rats.

    Conclusions:

    • CAM is a potent immunosuppressant that significantly enhances heart allograft survival in a fully mismatched rat model.
    • CAM exhibits superior efficacy compared to MMF, suggesting its potential as a next-generation immunosuppressive drug.
    • CAM-induced long-term graft acceptance is associated with donor-specific tolerance, characterized by reduced CTL responses, offering a promising avenue for transplantation tolerance induction.